Faeth Therapeutics: Guggenheim cuts target price to $69 from $70
FTH•Guggenheim cut its target price for Faeth Therapeutics to $69 from $70.
Related News
Scotiabank raises Block target price to $89 from $82
XYZ•
Innovative Industrial Properties raises target price to $46 from $44
IIPR•
Tempus AI target price raised to $95 from $76
TEM•
Broadridge Financial Solutions Inc: Raymond James cuts target price to $230 from $240
BR•
JPMorgan raises price target on Xometry to $140 from $120
XMTR•